Results 61 to 70 of about 6,357 (207)
Drug Testing and Analysis, Volume 17, Issue 9, Page 1545-1559, September 2025.A cost minimized immunoaffinity protocol was developed, which allows the direct purification of ERAs from human urine. After slight modification, the protocol is also applicable to serum and plasma and is fully compliant with WADA TD2024EPO. Compared to commercial EPO‐purification kits, the material costs are significantly lower.
Christian Reichel +2 more
wiley +1 more source
Saintika Medika, 2021 Chronic Kidney Disease (CKD) is a disorder of the structure / function of kidney> 3 months marked by pathology and renal damage marker and impairment Glomerular filtration rate (GFR).
Gunawan Widodo +3 more
doaj +1 more source
Brain and Behavior, Volume 15, Issue 8, August 2025.ABSTRACT Objective To identify potential druggable targets for Alzheimer's disease (AD) by analyzing circulating inflammatory proteins using Mendelian randomization (MR). Methods Two‐sample MR analysis was employed to investigate the causal relationships between 91 circulating inflammatory proteins and AD. The primary MR method utilized was the inverse
Hongliang An, Jianhong Gu, Taiping Li
wiley +1 more source
Epoetin alfa ja namaluva nefrotoksicnosta inducirana so cisplatin kaj staorci [PDF]
Makedonsko Farmacevtski Bilten, 2006 Klinickata efikasnost na cisplatin kako antitumorski lek e nesomnena, no dozno-limitiracki faktor za negova upotreba pretstavuva izrazitata nefrotoksicnost.
Dimce Zafirov +8 more
doaj
Development and 10-year history of a biosimilar: the example of Binocrit
Therapeutic Advances in Medical Oncology, 2018 Patent expirations for several biological products have prompted the development of alternative versions, termed ‘biosimilars’, which have comparable quality, safety and efficacy to a licensed biological medicine (also referred to as the ‘reference ...
Matti Aapro +4 more
doaj +1 more source
Онкогематология, 2018 Modern anticancer therapy due to its intensity and molecular biology orientation allows achieving higher efficiency and theoretically reducing the incidence of complications.
V. B. Larionova +5 more
doaj +1 more source
eJHaem, Volume 6, Issue 4, August 2025.ABSTRACT Background Anaemia significantly affects health outcomes and quality of life. While blood transfusion remains a common intervention, alternative treatments, such as iron supplementation and erythropoiesis‐stimulating agents (ESAs), offer potential to mitigate transfusion‐associated costs.
Hiro Farabi +9 more
wiley +1 more source
The QUEST initiative anemia study in ESRD: rationale and study protocol [PDF]
, 2007 No ...
Del Vecchio, Lucia +13 more
core
Utility and Safety of Romiplostim as an Alternative to Platelet Transfusion for Neonates
Pediatric Blood &Cancer, Volume 72, Issue 7, July 2025.ABSTRACT Thrombocytopenia is a common challenge in the neonatal intensive care unit, traditionally managed with platelet transfusions. However, transfusions are associated with significant risks, including increased mortality and neurodevelopmental impairment.
Rachel N. Zeno, Sara Awad, Harry Lesmana
wiley +1 more source
Small, Volume 21, Issue 29, July 24, 2025.This review presents a detailed overview of clinically approved nanoparticle therapeutics, classifying them by type and discussing their unique advantages in drug delivery. It highlights regulatory challenges across global markets and emphasizes the need for adaptive approval pathways.
Nimeet Desai +5 more
wiley +1 more source